❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Institute seminars

Institute seminars, autumn semester 2025

Open as PDF

Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

López A, Zobolas J, Dumontier T, Aittokallio T (2026)
Multi-modal learning with incomplete data
Nat Commun, 17 (1)
DOI 10.1038/s41467-026-77212-w, PubMed 42811071

Yaqub S, Valberg M, Bjørnbeth BA, Angelsen JH, Brudvik KW, Eilertsen IA, Fristedt R, Fristrup CW, Gilg S, Hemmingsson O, Isaksson B, Juel IS, Knudsen AR, Larsen PN, Mortensen KE, Olsen IC, Sandström P, Sandvik OM, Sparrelid E, Taflin H, Lothe RA, Taskén K, ASAC Study Group (2026)
Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
Lancet Gastroenterol Hepatol (in press)
DOI 10.1016/S2468-1253(26)00260-8, PubMed 42777749

Avershina E, Birkeland EE, Bucher-Johannessen C, Rounge TB (2026)
CRISPR-Cas immune repertoires as an ecological record of bacterial interactions with mobile genetic elements in the human gut
Gut Microbes, 18 (1), 2734649
DOI 10.1080/19490976.2026.2734649, PubMed 42768305

More selected publications

Most recent publications

Spangenberg H, Moe EL, Ødegård Fougner Ø, Sneeggen M, Pan M, Tan KW, Mateo Tortola M, Valenzuela C, Chang YY, Stenmark H, Raiborg C, Schink KO (2026)
A phosphoinositide and RAB switch controls early macropinocytosis
J Cell Sci (in press)
DOI 10.1242/jcs.265349, PubMed 42852846

Forcados C, Köksal H, Scherer E, Abrantes R, Dillard P, Duarte HO, Josefsson S, Gomes C, de Montlaur C, Hellesøy HTZ, Dunkel R, Smeland EB, Myklebust JH, Reis CA, McCormack E, Gelebart P, Inderberg EM, Wälchli S (2026)
Reviving low-affinity glycan-targeting CAR with combinatorial design
Cell Rep Med, 103108 (in press)
DOI 10.1016/j.xcrm.2026.103108, PubMed 42849448

Ning JF, Davis ZB, Zeb Q, Hinderlie P, Tuininga K, Wang L, Chaudhary S, Vue Y, Ma J, Zhu S, Zhang Y, Seeman ZJ, Malmberg KJ, Valamehr B, Largaespada DA, Zorko N, Felices M, Cichocki F, Miller JS, Chen CC (2026)
Induced pluripotent stem cell-derived natural killer cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager
Neuro Oncol, 28 (10), 2369-2383
DOI 10.1093/neuonc/noag154, PubMed 42434963

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)